Massachusetts General Hospital: Schizophrenia trials

The registry lists 35 Schizophrenia studies with Massachusetts General Hospital as lead sponsor. 4 are open to participants now and 19 have results posted.

Phase 2 1Phase 3 2Phase 4 16No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Effects of Auditory Stimulation During Sleep on Brain Networks in SchizophreniaRecruitingNCT06386588Not applicable
• Adapting the Tumor Board Model for Mental Illness and CancerRecruitingNCT05837598Not applicable
• Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental IllnessRecruitingNCT04940663Not applicable
• Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric PopulationsRecruitingNCT04296604Not applicable
• Bridge: Proactive Psychiatry Consultation and Case Management for Patients With CancerCompletedNCT03360695Not applicableResults posted
• Integrated Smoking Cessation Treatment for Smokers With Serious Mental IllnessCompletedNCT02845440Not applicableResults posted
• A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic SchizophreniaCompletedNCT02164981Phase 2Results posted
• Effects of Eszopiclone on Sleep and Memory in SchizophreniaCompletedNCT01641900Not applicableResults posted
• Effects of Pravastatin on Cholesterol, Inflammation and Cognition in SchizophreniaCompletedNCT01082588Phase 4Results posted
• D-cycloserine Augmentation of Cognitive Remediation in SchizophreniaCompletedNCT00963924Not applicableResults posted
• Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated HypertriglyceridemiaCompletedNCT00833976Phase 4Results posted
• Effects of Eszopiclone on Sleep-dependent Learning in SchizophreniaCompletedNCT00833547Not applicableResults posted
• Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for SchizophreniaCompletedNCT00742079Phase 4Results posted
• A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar DisorderCompletedNCT00621777Phase 4Results posted
• Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of SchizophreniaCompletedNCT00611806Phase 4Results posted
• Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With SchizophreniaCompletedNCT00595504Phase 4Results posted
• Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With SchizophreniaCompletedNCT00455702Phase 4Results posted
• Study of the Effects of Mecamylamine and Varenicline in SchizophreniaCompletedNCT00455650Not applicableResults posted
• The Effects of Nicotine on Cognition in SchizophreniaCompletedNCT00383747Phase 4Results posted
• Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With SchizophreniaCompletedNCT00345033Phase 4Results posted
• Rosiglitazone for Clozapine Induced Glucose Metabolism ImpairmentCompletedNCT00337350Phase 4Results posted
• Folate Supplementation in SchizophreniaCompletedNCT00249288Phase 4Results posted
• Trial of D-Cycloserine in SchizophreniaCompletedNCT00000371Phase 3Results posted
• Effects of Auditory Stimulation on Sleep and Memory in SchizophreniaActive, not recruitingNCT04783571Not applicable
• Measuring Beliefs and Norms About Persons With Mental IllnessCompletedNCT03656770Not applicable
• Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental IllnessCompletedNCT02594696Not applicable
• A Trial of Folate With B12 in Patients With Schizophrenia With Residual Symptoms in EthiopiaCompletedNCT01724476Phase 4
• Cross-Sectional Iloperidone IVGTTCompletedNCT01686815
• Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With SchizophreniaTerminatedNCT01576640Phase 4
• Once Weekly D-cycloserine for SchizophreniaWithdrawnNCT00964041Phase 4
• A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With SchizophreniaCompletedNCT00538070Not applicable
• A Placebo-Controlled Single-Dose Trial of Sildenafil in SchizophreniaCompletedNCT00455715Phase 4
• The Partners Genetics Collaborative Study of SchizophreniaCompletedNCT00319904
• Risperidone Augmentation in Patients With SchizophreniaCompletedNCT00289861Phase 4
• Glycine and D-Cycloserine in SchizophreniaWithdrawnNCT00000372Phase 3